Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.

Autor: Ma, Jiacheng1, Huo, XiaoJiao1, Jarpe, Matthew B.2, Kavelaars, Annemieke1, Heijnen, Cobi J.1 cjheijnen@mdanderson.org
Zdroj: Acta Neuropathologica Communications. 10/1/2018, Vol. 6 Issue 1, pN.PAG-N.PAG. 1p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje